Synlogic Appoints Molly Harper as Chief Business Officer

CAMBRIDGE, Mass., Sept. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of Molly Harper a... Biopharmaceuticals, Personnel Synlogic , synthetic biology, synthetic biotics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news